|
Biochem launches drug in China
1999-10-02
LAVAL, Quebec - BioChem Pharma Inc. announces the launch of Heptodin (lamivudine), the world's first oral antiviral treatment for chronic hepatitis B, in China, which has the highest prevalence of the disease in the world. Heptodin, known as Zeffix in most countries, is one of the first Western medicines to be granted a Class 1 drug certificate in China, offering the advantage of manufacturing exclusivity for the product in the treatment of hepatitis B for a period of eight years. ... ... | Note: this page has been archived under Muzi Premium Version and is only available to premium members. Please use the Premium Personal Password (PPP) to log in.
Premium Member Click Here Login
|
|  | | | Profile |
News21 | Gallery | Links | |
 | |
|
|
|